Amgen (AMGN) Interest Coverage Ratio: History & Chart

Amgen Inc.(AMGN)

Drug Manufacturers - General · Thousand Oaks, CA

$382.47+0.00 (+0.00%)

Delayed quote: Sep 10, 2026, 4:00 PM EDT

About Amgen Inc.

Amgen Inc., established in 1980 and headquartered in Thousand Oaks, California, is a global biotechnology leader focused on discovering, developing, manufacturing, and delivering groundbreaking human medicines. The company's scientific endeavors span several critical therapeutic categories, including inflammatory conditions, oncology and hematology, bone health, cardiovascular diseases, nephrology, and neuroscience. Its extensive portfolio features a range of significant pharmaceutical products. Notable examples include Enbrel, prescribed for conditions like plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta, which helps cancer patients by reducing the risk of infection linked to a low white blood cell count; Prolia, utilized in postmenopausal women to combat osteoporosis; and Xgeva, designed to prevent skeletal-related complications. Otezla offers relief for adult patients suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease. Aranesp addresses anemia and low red blood cell counts, while KYPROLIS is employed to treat patients with relapsed or refractory multiple myeloma. Furthermore, Repatha plays a vital role in lowering the incidence of major cardiovascular events such as myocardial infarction, stroke, and coronary revascularization. Amgen's comprehensive product lineup also encompasses Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. The company distributes its therapies worldwide, primarily serving healthcare providers, including physicians and their clinics, dialysis centers, hospitals, and pharmacies. Distribution is facilitated through pharmaceutical wholesale distributors, complemented by direct-to-consumer channels. Amgen actively engages in strategic collaborations. It has partnered with entities such as Novartis Pharma AG, UCB, Bayer HealthCare LLC, BeiGene, Ltd., Eli Lilly and Company, Datos Health, and Verastem, Inc., to jointly assess VS-6766 when combined with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. Another key alliance involves Kyowa Kirin Co., Ltd., for the co-development and commercialization of KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody targeting atopic dermatitis and other autoimmune conditions. Additionally, Amgen maintains research and development partnerships with Neumora Therapeutics, Inc. and Plexium, Inc.

Thousand Oaks, CA

31,500 employees

www.amgen.com

Healthcare / Drug Manufacturers - General

Sector: Healthcare
Industry: Drug Manufacturers - General
CEO: Robert A. Bradway

View full financials

AMGN Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

3.88x

INTEREST COVERAGE RATIO AVG TTM

4.55x

INTEREST COVERAGE RATIO AVG 3Y

2.95x

INTEREST COVERAGE RATIO AVG 5Y

4.31x

INTEREST COVERAGE RATIO AVG 10Y

5.86x

INTEREST COVERAGE RATIO AVG 15Y

6.02x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-14.68%

CURRENT VS 3Y AVG

+31.50%

CURRENT VS 5Y AVG

-10.02%

CURRENT VS 10Y AVG

-33.78%

CURRENT VS 15Y AVG

-35.53%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

6.88x

median of 82 covered companies

CURRENT VS SECTOR MEDIAN

-43.65%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Amgen Inc. (AMGN)	$206.42B	3.88x	4.55x	2.95x	4.31x
Novo Nordisk A/S (NVO)vs ›	$195.43B	30.34x	54.30x	123.94x	139.58x
Thermo Fisher Scientific Inc. (TMO)vs ›	$224.15B	5.71x	5.17x	6.77x	10.10x
Gilead Sciences, Inc. (GILD)vs ›	$179.79B	11.43x	6.56x	7.26x	7.18x
Abbott Laboratories (ABT)vs ›	$178.87B	23.60x	17.46x	17.67x	16.77x
AstraZeneca PLC (AZN)vs ›	$247.58B	8.11x	7.03x	5.51x	4.49x
Pfizer Inc. (PFE)vs ›	$157.59B	5.78x	5.55x	10.96x	11.04x
Danaher Corporation (DHR)vs ›	$141.00B	19.38x	19.02x	23.18x	23.65x
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$130.60B	357.95x	357.95x	174.48x	123.56x
Bristol-Myers Squibb Company (BMY)vs ›	$130.22B	7.26x	6.11x	6.76x	6.22x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Amgen Inc. (AMGN)

$206.42B

3.88x

4.55x

2.95x

4.31x

Novo Nordisk A/S (NVO)vs ›

$195.43B

30.34x

54.30x

123.94x

139.58x

Thermo Fisher Scientific Inc. (TMO)vs ›

$224.15B

5.71x

5.17x

6.77x

10.10x

Gilead Sciences, Inc. (GILD)vs ›

$179.79B

11.43x

6.56x

7.26x

7.18x

Abbott Laboratories (ABT)vs ›

$178.87B

23.60x

17.46x

17.67x

16.77x

AstraZeneca PLC (AZN)vs ›

$247.58B

8.11x

7.03x

5.51x

4.49x

Pfizer Inc. (PFE)vs ›

$157.59B

5.78x

5.55x

10.96x

11.04x

Danaher Corporation (DHR)vs ›

$141.00B

19.38x

19.02x

23.18x

23.65x

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$130.60B

357.95x

174.48x

123.56x

Bristol-Myers Squibb Company (BMY)vs ›

$130.22B

7.26x

6.11x

6.76x

6.22x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Amgen Inc. (AMGN)?

The interest coverage ratio for AMGN stock is 3.88x.

Is Amgen Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 3.88x is 10% below its 5-year average of 4.31x, around the middle of its 5-year range (1.20x–8.47x).

What is the TTM average interest coverage ratio for Amgen Inc. (AMGN)?

The TTM average interest coverage ratio for AMGN stock is 4.55x.

What is the 3Y average interest coverage ratio for Amgen Inc. (AMGN)?

The 3Y average interest coverage ratio for AMGN stock is 2.95x.

What is the 5Y average interest coverage ratio for Amgen Inc. (AMGN)?

The 5Y average interest coverage ratio for AMGN stock is 4.31x.

What is the 10Y average interest coverage ratio for Amgen Inc. (AMGN)?

The 10Y average interest coverage ratio for AMGN stock is 5.86x.

What is the 15Y average interest coverage ratio for Amgen Inc. (AMGN)?

The 15Y average interest coverage ratio for AMGN stock is 6.02x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	5.22x
2026-03-31	4.06x
2025-12-31	6.04x
2025-09-30	3.69x
2025-06-30	3.73x
2025-03-31	1.63x
2024-12-31	3.09x
2024-09-30	2.64x
2024-06-30	2.36x
2024-03-31	1.20x
2023-12-31	1.55x
2023-09-30	2.66x
2023-06-30	3.57x
2023-03-31	3.54x
2022-12-31	5.37x
2022-09-30	7.23x
2022-06-30	6.63x
2022-03-31	8.47x
2021-12-31	6.88x
2021-09-30	8.03x
2021-06-30	2.95x
2021-03-31	7.47x
2020-12-31	6.31x
2020-09-30	8.12x
2020-06-30	7.85x
2020-03-31	6.81x
2019-12-31	6.80x
2019-09-30	7.91x
2019-06-30	8.07x
2019-03-31	7.21x
2018-12-31	6.77x
2018-09-30	6.54x
2018-06-30	8.16x
2018-03-31	8.07x
2017-12-31	6.76x
2017-09-30	7.50x
2017-06-30	8.40x
2017-03-31	7.95x
2016-12-31	7.58x
2016-09-30	7.78x
2016-06-30	7.60x
2016-03-31	8.17x
2015-12-31	7.16x
2015-09-30	8.29x
2015-06-30	7.49x
2015-03-31	8.02x
2014-12-31	5.59x
2014-09-30	5.45x
2014-06-30	6.74x
2014-03-31	5.27x
2013-12-31	4.55x
2013-09-30	6.57x
2013-06-30	6.43x
2013-03-31	5.48x
2012-12-31	3.74x
2012-09-30	5.25x
2012-06-30	6.21x
2012-03-31	6.29x
2011-12-31	5.96x
2011-09-30	3.32x
2011-06-30	10.92x
2011-03-31	9.58x
2010-12-31	6.59x
2010-09-30	9.86x
2010-06-30	10.32x
2010-03-31	10.21x
2009-12-31	7.91x
2009-09-30	11.55x
2009-06-30	9.71x
2009-03-31	8.99x

DATE

INTEREST COVERAGE RATIO

2026-06-30

5.22x

2026-03-31

4.06x

2025-12-31

6.04x

2025-09-30

3.69x

2025-06-30

3.73x

2025-03-31

1.63x

2024-12-31

3.09x

2024-09-30

2.64x

2024-06-30

2.36x

2024-03-31

1.20x

2023-12-31

1.55x

2023-09-30

2.66x

2023-06-30

3.57x

2023-03-31

3.54x

2022-12-31

5.37x

2022-09-30

7.23x

2022-06-30

6.63x

2022-03-31

8.47x

2021-12-31

6.88x

2021-09-30

8.03x

2021-06-30

2.95x

2021-03-31

7.47x

2020-12-31

6.31x

2020-09-30

8.12x

2020-06-30

7.85x

2020-03-31

6.81x

2019-12-31

6.80x

2019-09-30

7.91x

2019-06-30

8.07x

2019-03-31

7.21x

2018-12-31

6.77x

2018-09-30

6.54x

2018-06-30

8.16x

2018-03-31

8.07x

2017-12-31

6.76x

2017-09-30

7.50x

2017-06-30

8.40x

2017-03-31

7.95x

2016-12-31

7.58x

2016-09-30

7.78x

2016-06-30

7.60x

2016-03-31

8.17x

2015-12-31

7.16x

2015-09-30

8.29x

2015-06-30

7.49x

2015-03-31

8.02x

2014-12-31

5.59x

2014-09-30

5.45x

2014-06-30

6.74x

2014-03-31

5.27x

2013-12-31

4.55x

2013-09-30

6.57x

2013-06-30

6.43x

2013-03-31

5.48x

2012-12-31

3.74x

2012-09-30

5.25x

2012-06-30

6.21x

2012-03-31

6.29x

2011-12-31

5.96x

2011-09-30

3.32x

2011-06-30

10.92x

2011-03-31

9.58x

2010-12-31

6.59x

2010-09-30

9.86x

2010-06-30

10.32x

2010-03-31

10.21x

2009-12-31

7.91x

2009-09-30

11.55x

2009-06-30

9.71x

2009-03-31

8.99x

Interest Coverage Ratio: 3.88x

AMGN Interest Coverage Ratio

AMGN Average Interest Coverage Ratio Chart

AMGN Current vs Average Interest Coverage Ratio Chart

AMGN Interest Coverage Ratio Metrics

AMGN Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

AMGN Interest Coverage Ratio History

Related Metrics